ICLUSIG FILM-COATED TABLET 15 MG

ICLUSIG FILM-COATED TABLET 15 MG

Kategori: Drug Info Tersedia
Untuk maklumat lanjut, lawati laman web rasmi kami di farmakopedia.com

Penerangan

Manufacturer
Takeda Ireland Limited(IRELAND)

Registraction Number
MAL19056102ACRZ

Content:
Each film-coated tablet contains:
Ponatinib (as hydrochloride): 15 mg
Indications:
Chronic Myeloid Leukemia (CML): Used in adult patients with chronic phase, accelerated phase, or blast phase CML who are resistant to dasatinib or nilotinib, intolerant to dasatinib or nilotinib, or have the T315I mutation.
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Used in adult patients with Ph+ ALL who are resistant to dasatinib, intolerant to dasatinib, or have the T315I mutation.
Instructions:
Dosage: The recommended starting dose is 45 mg once daily. Treatment should be continued as long as the patient does not show evidence of disease progression or unacceptable toxicity.
Administration: Take the tablet with or without food. Swallow the tablet whole with water. It is important to follow your doctor's instructions regarding the timing and duration of the medication.

 

Lebih maklumat tentang Complete Wellness
Complete Wellness
Complete Wellness General Health | Healthy Lifestyle | Drug & Supplement Information Provider ~Complete Wellness